Vanderbilt-Ingram Cancer Center

Vanderbilt-Ingram website >

Authors on the study included, from left, Jennifer Pietenpol, PhD, Melinda Sanders, MD, Brian Lehmann, PhD, Vandana Abramson, MD, and Yu Shyr, PhD. (photo by Donn Jones)
December 15, 2023

Clinical trial shows efficacy for atezolizumab combined with carboplatin

By Tom Wilemon
Sam S. Chang, MD, MBA
December 14, 2023

Sam S. Chang recognized by the American Urological Association

The American Urological Association has announced that Vanderbilt’s Sam S. Chang, MD, MBA, is one of its 2024 award recipients.

By Tom Wilemon
The visit was the first time a group of Ukrainian oncologists came to VUMC to learn about cancer research and care.
November 30, 2023

Ukrainian oncologists visit Vanderbilt-Ingram Cancer Center

A group of Ukrainian oncologists recently visited Vanderbilt-Ingram Cancer Center where they toured research labs, observed tumor board meetings, met with several Vanderbilt oncologists, and attended the 23rd Annual Retreat for Cancer Biology.

By Tom Wilemon
Keith Obstein, MD, MPH, center, was presented the award by Kenneth Holroyd, MD, MBA, and Jennifer Pietenpol, PhD. (photo by Donn Jones)
November 17, 2023

Keith Obstein receives inaugural Brock Family Center Innovator of the Year Award

Keith Obstein, MD, MPH, has received the inaugural Innovator of the Year Award from the Brock Family Center for Applied Innovation in recognition of his achievements in developing and commercializing a magnetic, flexible colonoscopy system with the potential to provide a safer alternative to standard colonoscopy.

By Jill Clendening
November 17, 2023

Vanderbilt’s Dr. W. Kimryn Rathmell to be appointed director of the National Cancer Institute

Kimryn Rathmell, MD, PhD, MMHC, the Hugh Jackson Professor of Medicine and chair of the Department of Medicine at Vanderbilt University Medical Center (VUMC), has been named director of the National Cancer Institute

By John Howser
Mark Denison, MD, and Xiaotao Lu, MS, are among those on a new list of scientists whose papers have been cited the most frequently by other researchers. (photo by Erin O. Smith)
November 15, 2023

Twelve at Vanderbilt are among world’s highly cited researchers

Twelve current investigators at Vanderbilt University Medical Center and Vanderbilt University are on this year’s list of scientists whose papers have been cited the most frequently by other researchers.

By Bill Snyder
November 3, 2023

GE Healthcare, Vanderbilt University Medical Center and the University Medicine Essen validate Artificial Intelligence models for predicting patient response to immunotherapies

By VUMC News and Communications
October 26, 2023

Debra Friedman named deputy director of Vanderbilt-Ingram Cancer Center

Internationally recognized cancer survivorship expert Debra Friedman, MD, MS, has been named deputy director of Vanderbilt-Ingram Cancer Center
By Tom Wilemon
October 17, 2023

Vanderbilt-Ingram Cancer Center earns NCI Merit Award

Vanderbilt-Ingram Cancer Center has earned a Merit Extension Award from the National Cancer Institute in recognition of more than a decade of sustained exceptional progress.
By Tom Wilemon
October 12, 2023

Prostate cancer survivors symposium set for Nov. 11

Vanderbilt University Medical Center Department of Urology and Vanderbilt-Ingram Cancer Center are hosting a symposium for prostate cancer survivors and their families on Saturday, Nov. 11.
By Tom Wilemon
October 12, 2023

Symposium for patients, caregivers and family members offers important information on stomach cancer, Nov. 4

A Vanderbilt symposium on Nov. 4 offers detailed information for patients, caregivers and family members about stomach cancer.
By Tom Wilemon
October 10, 2023

Multidisciplinary care crucial in guiding Vanderbilt employee’s bile duct cancer journey

Blane Hollingsworth became the first patient at Vanderbilt to undergo a liver transplant under the protocol for cholangiocarcinoma, or bile duct cancer.
By Matt Batcheldor
October 5, 2023

Study validates pyrvinium as treatment to prevent stomach cancer

A Vanderbilt study found that a drug that has been used for decades for intestinal pinworms, can be repurposed as a preventative treatment for stomach cancer.
By Tom Wilemon
1 … 3 4 5 6 7 … 26